Major Medical Concerns Regarding EC/MAP, Plan B: APFLI Statement (9/04, updated 2006)

Emergency Contraception Supporters want EC (MAP – Morning After Pill) to be freely available in all county health departments (to girls as young as 14, without parental knowledge) nationwide. They are also pressuring the FDA to release EC over-the-counter (OTC). When the FDA denied this request in 5/04, Barr Labs and other EC supporters returned to the FDA seeking that EC be released OTC to all women over age 16, and by prescription (without parental knowledge) to girls under age 16.  In 2005, the FDA has again postponed this OTC approval. The EC supporters insist that EC will: • Decrease pregnancy rates • Decrease abortion rates However, they do not provide medical facts to back up these claims, nor do they want to discuss the following points… OUTLINE OF MAIN MEDICAL CONCERNS REGARDING EMERGENCY CONTRACEPTION (EC/MAP): • increased exposure to STDs/STIs — Chlamydia: 45% inc OTC in Sweden, 13% inc in Washington State’s more restrictive pharmacist direct pilot program for teens • increased ectopic pregnancy rates — 3 times the expected rate • new data showing increased pregnancy and abortion rates • lack of medical oversight • increased sexual predation — statutory rape, incest • increased sexual activity • danger of high-dose estrogens on young female bodies has not been well evaluated • danger of long-term damage from high-dose EC has not been well evaluated These concerns will now be discussed in more detail: Increased STD/STI Rates Associated with EC Use. The ACOG (American College of Obstetrics and Gynecology) recommends regular STD testing for sexually active women, and especially for those outside a monogamous relationship.  That there would be an increase in sexual activity and exposure to STDs with the use of...